Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
Số trang: 12
Loại file: pdf
Dung lượng: 1.93 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The incidence of colorectal cancer (CRC) is considered to be the third-highest malignant tumor among all carcinomas. The alterations in cellular bioenergetics (metabolic reprogramming) are associated with several malignant phenotypes in CRC, such as tumor cell proliferation, invasion, metastasis, chemotherapy resistance, as well as promotes its immune escape.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Colorectal cancer Prognostic biomarker Tumor cell proliferation Cellular bioenergetics Metabolic reprogrammingGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 141 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 115 0 0 -
12 trang 92 0 0
-
19 trang 74 0 0
-
17 trang 62 0 0
-
9 trang 39 0 0
-
12 trang 37 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0